Risk of ESRD in T1DM patients has fallen markedly in finland

December 27, 2017

(HealthDay)—The cumulative risk of end-stage renal disease (ESRD) among patients with type 1 diabetes has declined over time in Finland, according to a study published online Dec. 20 in Diabetes Care.

Jaakko Helve, M.D., from the University of Helsinki in Finland, and analyzed data from all patients <30 years old diagnosed with type 1 diabetes in Finland between 1965 and 2011. In an effort to assess how risk of ESRD changed over time, 29,906 patients were followed until start of renal replacement therapy, death, or end of follow-up at the end of 2013.

The researchers found that over a median of 20 years of follow-up, there were 1,543 ESRD cases and 4,185 deaths. Twenty years after diabetes diagnosis, the cumulative risk of ESRD was 2.2 percent; the risk grew to 7 percent after 30 years. Among patients diagnosed between 1995 and 2011, the relative risk of ESRD was 0.13 versus those diagnosed between 1965 and 1979. The lowest risk of ESRD was in patients <5 years old at the time of diagnosis, while the highest cumulative risk of ESRD estimated from time of birth was in patients aged 5 to 9 years at diabetes diagnosis.

"The cumulative risk of ESRD has decreased markedly during the past five decades," the authors write. "This highlights the importance of modern treatment of diabetes and diabetic nephropathy."

Explore further: Drop in incidence of end-stage renal disease due to diabetes

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Drop in incidence of end-stage renal disease due to diabetes

November 8, 2017
(HealthDay)—The incidence of end-stage renal disease (ESRD) with diabetes listed as the primary cause (ESRD-D) decreased across the United States from 2000 to 2014, according to a study published online Nov. 2 in Morbidity ...

Cumulative incidence of ESRD low in patients with type 1 DM

November 8, 2016
(HealthDay)—Patients with type 1 diabetes diagnosed at age 15 to 27 years have low cumulative incidence of end-stage renal disease (ESRD) and increased mortality during long-term follow-up, according to a study published ...

Kidney damage seen in most patients with long-lasting T1D

October 30, 2017
(HealthDay)—Most patients with type 1 diabetes (T1D) of long duration have some degree of kidney disease, according to a study published online Oct. 4 in Diabetes Care.

Metabolites linked to renal decline, time to ESRD in T1DM

January 19, 2017
(HealthDay)—Serum levels of seven modified metabolites are associated with renal function decline and time to end-stage renal disease (ESRD) among patients with type 1 diabetes (T1D), according to a study published online ...

Decline in eGFR mainly linear in type 1 diabetes

September 22, 2016
(HealthDay)—For patients with type 1 diabetes, the decline of estimated glomerular filtration rate (eGFR) is mainly linear, according to a study published online Sept. 19 in Diabetes Care.

Recommended for you

Fat tissue may play a crucial role in the progression of diabetes, challenging long established notions

October 12, 2018
A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional ...

Does breastfeeding hormone protect against type 2 diabetes?

October 12, 2018
(HealthDay)—The hormone prolactin—most commonly associated with breastfeeding—may play a role in reducing the risk of type 2 diabetes, a new study suggests.

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

Planned intermittent fasting may help reverse type 2 diabetes, suggest doctors

October 10, 2018
Planned intermittent fasting may help to reverse type 2 diabetes, suggest doctors writing in the journal BMJ Case Reports after three patients in their care, who did this, were able to cut out the need for insulin treatment ...

New discovery restores insulin cell function in type 2 diabetes

October 8, 2018
By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown ...

Weight loss drug shows positive effect on diabetes

October 4, 2018
At the 2018 Meeting of the European Association for the Study of Diabetes, Brigham and Women's Hospital investigators from the Thrombolysis in Myocardial Infarction (TIMI) Study Group presented diabetes-related findings from ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.